Charting the Course Podcast: Antivirals for Refractory CMV Infections
Stream now to learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections from expert faculty, Atul Humar, MD, FRCP (C).
Decera Clinical Education Infectious Disease Podcast · Atul Humar MD FRCP (C)
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:
- Comparisons of available CMV antiviral therapies:
- Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir
- Considerations for renal function monitoring with ganciclovir and valganciclovir
- A treatment algorithm for relapsed/refractory CMV
- The latest clinical trial data and guideline recommendations
Presenter:
Atul Humar, MD, FRCP (C)
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
Link to full program:
https://bit.ly/4lOa2kA
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.